[{"id":"28eabe08-4713-4401-acdf-9897ef828ff4","acronym":"","url":"https://clinicaltrials.gov/study/NCT04388371","created_at":"2021-01-18T21:11:01.562Z","updated_at":"2024-07-02T16:36:26.628Z","phase":"Phase 1","brief_title":"Glutamine PET Imaging in LAM","source_id_and_acronym":"NCT04388371","lead_sponsor":"Vanderbilt University Medical Center","biomarkers":" VEGFD","pipe":" | ","alterations":" VEGFD elevation","tags":["VEGFD"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e VEGFD elevation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e everolimus • sirolimus"],"overall_status":"Completed","enrollment":" Enrollment 5","initiation":"Initiation: 10/18/2019","start_date":" 10/18/2019","primary_txt":" Primary completion: 06/30/2021","primary_completion_date":" 06/30/2021","study_txt":" Completion: 08/10/2021","study_completion_date":" 08/10/2021","last_update_posted":"2021-08-11"}]